HB 112 Louisiana House · 2025 Regular Session

DRUGS/PRESCRIPTION: Provides relative to the prescribing, administering, and dispensing of drugs for off-label use

HB 112 allows healthcare professionals with prescriptive authority to prescribe, administer, or dispense FDA-approved drugs for off-label uses - such as different dosages, age groups, or unapproved medical conditions - without restrictions from licensing boards. It directly affects doctors, nurses, and other licensed prescribers by removing barriers to using drugs in ways not specifically FDA-approved for that purpose. The bill prohibits licensing commissions from limiting these prescribing practices, ensuring healthcare providers can make clinical decisions based on patient needs. Currently pending in the Health and Welfare Committee, the bill has not yet been voted on or passed.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2025
Committee Review
Floor Vote
Governor
Introduced Mar 25, 2025 Last action Apr 14, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
4
Key actions
0
Committee
2
Apr 14, 2025
Committee
Read by title, under the rules, referred to the Committee on Health and Welfare.
lower
Mar 25, 2025
Committee
Under the rules, provisionally referred to the Committee on Health and Welfare.
lower
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Kathy Edmonston
Kathy Edmonston
RRepublican
LA
88